---
title: "Major Aveanna Stakeholders Quietly Unload Massive Blocks of Stock"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/291021958.md"
description: "Major stakeholders of Aveanna Healthcare Holdings (AVAH) sold significant stock blocks on June 26, 2026. J.H. Whitney Equity Partners VII sold ~919k shares for $7.35M, while Robert M. Williams and Paul Vigano each sold 1M shares for $8M. This occurs despite recent positive developments, including a $175.5M acquisition, raised 2026 guidance, and an analyst upgrade. TipRanks' AI Analyst rates AVAH as Neutral, citing strong operations and low valuation offset by high leverage."
datetime: "2026-06-27T02:04:21.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/291021958.md)
  - [en](https://longbridge.com/en/news/291021958.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/291021958.md)
---

# Major Aveanna Stakeholders Quietly Unload Massive Blocks of Stock

New insider activity at Aveanna Healthcare Holdings ( (AVAH) ) has taken place on June 26, 2026.

### TipRanks' Prime Week Sale - 70% Off

-   Unlock powerful investing tools and data-driven insights with TipRanks Premium for more confident investment decisions.
-   Discover top stock picks and new investment opportunities through TipRanks' Smart Investor Newsletter.

Aveanna Healthcare Holdings has seen notable activity from its significant shareholders, with three major stock sales reported. J.H. Whitney Equity Partners VII, LLC divested 919,389 shares in a transaction totaling $7,355,112. In separate moves, significant shareholder Robert M. Williams sold 1,000,000 shares for $8,000,000, and fellow significant shareholder Paul Vigano also sold 1,000,000 shares for $8,000,000. These combined transactions represent a substantial shift in holdings among key stakeholders of Aveanna Healthcare Holdings.

**Recent Updates on AVAH stock**

Aveanna Healthcare’s shares have been volatile over the last day as investors digested its completed $175.5M Family First Homecare acquisition and the resulting 2026 guidance raise, which signals stronger revenue and EBITDA contributions from expanded pediatric private duty nursing scale. An upgrade from a major firm highlighted solid execution on preferred payor relationships and argued that reimbursement worries are overdone, noting that a growing payor mix and market presence should buffer Medicaid policy risk even as the stock trades near perceived trough valuation.

**Spark’s Take on AVAH Stock**

According to Spark, TipRanks’ AI Analyst, AVAH is a Neutral.

AVAH scores above average primarily due to improving operations and upbeat forward outlook (raised 2026 guidance and strong recent growth), supported by a low P/E valuation. The biggest offset is financial risk from high leverage and limited debt coverage, while technicals show strong trend strength but overbought conditions that can increase near-term volatility.

To see Spark’s full report on AVAH stock,  
click here.

**More about Aveanna Healthcare Holdings**

**YTD Price Performance:** 3.79%

**Average Trading Volume:** 1,616,653

**Technical Sentiment Signal:** Strong Buy

**Current Market Cap:** $1.85B

### Related Stocks

- [AVAH.US](https://longbridge.com/en/quote/AVAH.US.md)

## Related News & Research

- [Major Aveanna Stakeholders Quietly Unload Massive Positions](https://longbridge.com/en/news/291620130.md)
- [How the 'Nostradamus of AI' failed to spot a market crash](https://longbridge.com/en/news/294580418.md)
- [3 genius artificial intelligence (AI) stocks to buy right now](https://longbridge.com/en/news/294816326.md)
- [Meet the Gen Z AI whiz at the center of a hedge fund meltdown](https://longbridge.com/en/news/294425537.md)
- [What an AI bust in 2026 would do to stocks across the board](https://longbridge.com/en/news/294605337.md)